CompletedNot Applicable

Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome

Iraq100 participantsStarted 2022-07-19

Plain-language summary

Studying the effects of adding probiotics to the drug regimen of patients with diarrhea predominant IBS

Age range16 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Age \> 55
✕. Celiac disease
✕. Inflammatory bowel disease (ulcerative colitis \& Crohn's)
✕. Thyroid disease
✕. Colonic CA
✕. Lactose intolerance
✕. Alarming features (anemia, blood in the stool, weight loss, abdominal masses, dysphagia, family history of GIT malignancy)
✕. Preexisting use of antibiotics in the previous 3 months.

The change in bowel habits (based on the IBS-SSS) after treatment with a multi-strain probiotic or standard treatment, and compared with baseline.

Timeframe: Three months

NCT IDNCT05523427

SponsorUniversity of Mosul

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-21